acrolein has been researched along with 2,2'-(hydroxynitrosohydrazono)bis-ethanamine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhatnagar, A; Bolli, R; Guo, Y; Prabhu, SD; Tsai, LL; Vondriska, TM; Wang, GW; Zhang, J; Zhang, S; Zong, NC | 1 |
1 other study(ies) available for acrolein and 2,2'-(hydroxynitrosohydrazono)bis-ethanamine
Article | Year |
---|---|
Acrolein consumption exacerbates myocardial ischemic injury and blocks nitric oxide-induced PKCepsilon signaling and cardioprotection.
Topics: Acrolein; Animals; Cardiotonic Agents; Diet; Dose-Response Relationship, Drug; Mice; Mice, Inbred ICR; Mitochondria, Heart; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Protein Kinase C-epsilon; Protein Transport; Signal Transduction; Triazenes | 2008 |